![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist
Holko, Przemysław, Kawalec, Paweł, Pilc, AndrzejLanguage:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-018-0653-2
Date:
April, 2018
File:
PDF, 872 KB
english, 2018